Eduardo C. B.
- Country
- Spain
- Department
- Oncology
Research Overview
Data & Insights
Has run more than one trial at 0 of 40 partner sites.
Specializations
Oncological Focus
The investigator specializes in the treatment of pancreatic adenocarcinoma, with particular emphasis on metastatic disease management. Their research explores innovative therapeutic approaches for patients with advanced pancreatic cancer.
- Pancreatic Cancer Treatment
- Metastatic Disease Management
- First-line Therapy Development
Their work includes evaluating targeted therapies for specific molecular subtypes of pancreatic cancer.
Molecular Targeting
The investigator focuses on molecular-guided treatment approaches, particularly studying CLDN18.2-positive tumors. Their expertise includes investigating targeted therapeutic agents in pancreatic cancer treatment.
- Biomarker-Driven Therapy
- Targeted Treatment Strategies
- Molecular Classification
They specialize in evaluating novel targeted therapies for specific patient populations.
Therapeutic Innovation
The investigator studies combination therapy approaches in pancreatic cancer, including the integration of novel biological agents with established treatment regimens. Their research encompasses evaluation of treatment safety and efficacy.
- Combination Therapy Development
- Treatment Safety Assessment
- Survival Outcome Analysis
Their work involves developing and validating new therapeutic combinations for pancreatic cancer treatment.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.